The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Why are Biologics Drugs Different
Read More
post
Why Hire an Experienced CMC Consultant for Your Early Phase Studies
Read More
webinar
Formulation and Analytical Considerations for Preclinical and Early Phase Pharmaceutical Development
Read More
post
Components of a Successful Regulatory Strategy for Drug Development
Read More
Let's move from science to success.
Let’s Talk